MX2010008308A - Tratamiento para trastornos relacionados con los ojos. - Google Patents
Tratamiento para trastornos relacionados con los ojos.Info
- Publication number
- MX2010008308A MX2010008308A MX2010008308A MX2010008308A MX2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- ocular
- related disorders
- macular degeneration
- diabetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Abstract
(Ver fórmula (I)) Se describe un tratamiento para trastornos relacionados con los ojos, tales como la degeneración macular, y preferentemente degeneración macular asociada a la edad, retinopatía diabética, y edema macular diabético, utilizando un compuesto de Fórmula 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3507308P | 2008-03-10 | 2008-03-10 | |
PCT/US2009/036119 WO2009114373A1 (en) | 2008-03-10 | 2009-03-05 | Treatment for ocular-related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010008308A true MX2010008308A (es) | 2010-08-11 |
Family
ID=40583469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010008308A MX2010008308A (es) | 2008-03-10 | 2009-03-05 | Tratamiento para trastornos relacionados con los ojos. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP2285378A1 (es) |
JP (1) | JP2011513488A (es) |
KR (1) | KR20110009084A (es) |
CN (1) | CN101965188A (es) |
AR (1) | AR070975A1 (es) |
AU (1) | AU2009223501A1 (es) |
BR (1) | BRPI0909659A2 (es) |
CA (1) | CA2717991A1 (es) |
CL (1) | CL2009000551A1 (es) |
CO (1) | CO6290691A2 (es) |
CR (1) | CR11644A (es) |
DO (1) | DOP2010000266A (es) |
IL (1) | IL207906A0 (es) |
MA (1) | MA32211B1 (es) |
MX (1) | MX2010008308A (es) |
NI (1) | NI201000131A (es) |
NZ (1) | NZ587906A (es) |
RU (1) | RU2010141560A (es) |
SV (1) | SV2010003658A (es) |
TW (1) | TW200950784A (es) |
WO (1) | WO2009114373A1 (es) |
ZA (1) | ZA201005337B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR074776A1 (es) | 2008-12-18 | 2011-02-09 | Sanofi Aventis | Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente |
EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2699568C (en) * | 1999-12-24 | 2013-03-12 | Aventis Pharma Limited | Azaindoles |
AU778417B2 (en) * | 2000-02-25 | 2004-12-02 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
KR101487027B1 (ko) * | 2005-09-30 | 2015-01-28 | 미카나 테라퓨틱스, 인크. | 치환된 피라졸 화합물 |
CL2007002617A1 (es) * | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
-
2009
- 2009-03-05 CA CA2717991A patent/CA2717991A1/en not_active Abandoned
- 2009-03-05 AU AU2009223501A patent/AU2009223501A1/en not_active Abandoned
- 2009-03-05 EP EP09718970A patent/EP2285378A1/en not_active Withdrawn
- 2009-03-05 BR BRPI0909659A patent/BRPI0909659A2/pt not_active IP Right Cessation
- 2009-03-05 CN CN2009801075816A patent/CN101965188A/zh active Pending
- 2009-03-05 RU RU2010141560/15A patent/RU2010141560A/ru unknown
- 2009-03-05 WO PCT/US2009/036119 patent/WO2009114373A1/en active Application Filing
- 2009-03-05 JP JP2010550758A patent/JP2011513488A/ja not_active Withdrawn
- 2009-03-05 KR KR1020107019973A patent/KR20110009084A/ko not_active Application Discontinuation
- 2009-03-05 NZ NZ587906A patent/NZ587906A/en not_active IP Right Cessation
- 2009-03-05 MX MX2010008308A patent/MX2010008308A/es not_active Application Discontinuation
- 2009-03-09 TW TW098107567A patent/TW200950784A/zh unknown
- 2009-03-09 CL CL2009000551A patent/CL2009000551A1/es unknown
- 2009-03-09 AR ARP090100835A patent/AR070975A1/es not_active Application Discontinuation
-
2010
- 2010-07-27 ZA ZA2010/05337A patent/ZA201005337B/en unknown
- 2010-07-29 NI NI201000131A patent/NI201000131A/es unknown
- 2010-08-24 CR CR11644A patent/CR11644A/es not_active Application Discontinuation
- 2010-08-31 IL IL207906A patent/IL207906A0/en unknown
- 2010-09-01 CO CO10108103A patent/CO6290691A2/es not_active Application Discontinuation
- 2010-09-02 DO DO2010000266A patent/DOP2010000266A/es unknown
- 2010-09-07 SV SV2010003658A patent/SV2010003658A/es unknown
- 2010-10-06 MA MA33226A patent/MA32211B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CO6290691A2 (es) | 2011-06-20 |
WO2009114373A1 (en) | 2009-09-17 |
TW200950784A (en) | 2009-12-16 |
EP2285378A1 (en) | 2011-02-23 |
DOP2010000266A (es) | 2010-09-30 |
KR20110009084A (ko) | 2011-01-27 |
ZA201005337B (en) | 2011-04-28 |
MA32211B1 (fr) | 2011-04-01 |
CN101965188A (zh) | 2011-02-02 |
IL207906A0 (en) | 2010-12-30 |
CA2717991A1 (en) | 2009-09-17 |
BRPI0909659A2 (pt) | 2015-09-22 |
NZ587906A (en) | 2011-12-22 |
JP2011513488A (ja) | 2011-04-28 |
RU2010141560A (ru) | 2012-04-20 |
CR11644A (es) | 2010-11-22 |
AR070975A1 (es) | 2010-05-19 |
NI201000131A (es) | 2011-09-29 |
CL2009000551A1 (es) | 2009-08-21 |
SV2010003658A (es) | 2011-01-31 |
AU2009223501A1 (en) | 2009-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX347226B (es) | Tratamiento de enfermedad ocular. | |
MY175318A (en) | Androgen composition for treating an opthalmic condition | |
TN2013000275A1 (en) | Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) | |
MX358176B (es) | El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea. | |
WO2012080497A3 (en) | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases | |
SG178963A1 (en) | Compounds as tyrosine kinase modulators | |
JO3039B1 (ar) | طريقة ومركب لعلاج فرط ضغط العين والجلوكوما | |
ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
MX2009003316A (es) | Derivados de pirazina-2-carboxamida como moduladores receptores de cb2. | |
WO2007098122A3 (en) | Methods for the treatment of macular degeneration and related eye conditions | |
EA201490721A1 (ru) | Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы | |
MX348024B (es) | Compuestos de adamantilo. | |
GEP20156315B (en) | Oxazoline and isoxazoline derivatives as crac modulators | |
EA201190337A1 (ru) | Способ лечения | |
WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
NZ597866A (en) | Therapeutic lactams | |
WO2009109501A3 (en) | Ocular pharmaceutical compositions | |
WO2007089673A8 (en) | Compositions and methods for treatment of ophthalmic diseases and disorders | |
MX2010008308A (es) | Tratamiento para trastornos relacionados con los ojos. | |
MX2014003883A (es) | Inhibidores de monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y transtornos relacionados. | |
WO2008124151A3 (en) | Use of creatine compounds for the treatment of eye disorders | |
UA103197C2 (uk) | Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами | |
WO2010046865A3 (en) | Ophthalmic administration of a composition including brimonidine as a mist | |
TW200744627A (en) | Methods for the treatment of macular degeneration and related eye conditions | |
TN2010000368A1 (en) | Treatment for ocular-related disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |